Market Welfare: Why Are Covid-19 Vaccines Still Underfunded?

11 Jun

“To get roughly 70% of the planet’s population inoculated by April, the IMF calculates, would cost just $50bn. The cumulative economic benefit by 2025, in terms of increased global output, would be $9trn, to say nothing of the many lives that would be saved.”

The Economist frames this as an opportunity for G7. And it is. But it is also an opportunity for third-world countries, which plausibly can borrow $50bn given the return on investment. The fact that money hasn’t already been allocated poses a puzzle. Is it because governments think about borrowing decisions based on whether or not a policy is tax revenue positive (which a 180x return ought to be even with low tax collection and assessment rates)? Or is it because we don’t have a marketplace where we can transact on this information? If so, it seems like an important hole.

Here’s another way to look at this point. Among countries where the profits mostly go to a few, why do the people at the top not come to invest together so that they can harvest profits later? Brunei is probably an ok example.

This site uses Akismet to reduce spam. Learn how your comment data is processed.